Christian Bernloehr

Title: Christian Bernloehr: Innovator in CHO Cell Technology

Introduction

Christian Bernloehr is a notable inventor based in Ingelheim am Rhein, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of methods for enhancing protein production in Chinese Hamster Ovary (CHO) cells. With a total of 2 patents, Bernloehr's work is pivotal in advancing biopharmaceutical manufacturing processes.

Latest Patents

Bernloehr's latest patents focus on the identification of genomic integration sites for heterologous polynucleotides in CHO cells. These innovations lead to high RNA and protein production, which is crucial for the biopharmaceutical industry. Specifically, his patents describe CHO cells that contain at least one heterologous polynucleotide stably integrated into the S100A gene cluster of the CHO genome. This integration allows for the reliable and high-yield production of proteins of interest, making it a significant advancement in the field.

Career Highlights

Christian Bernloehr is currently associated with Boehringer Ingelheim International GmbH, where he continues to push the boundaries of biotechnological research. His work has not only contributed to the scientific community but has also had practical applications in the production of therapeutic proteins.

Collaborations

Throughout his career, Bernloehr has collaborated with esteemed colleagues such as Markus Mueller and Jochen Schaub. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Christian Bernloehr's contributions to CHO cell technology exemplify the impact of innovative thinking in biotechnology. His patents and ongoing work at Boehringer Ingelheim International GmbH are paving the way for more efficient protein production methods, which are essential for the development of biopharmaceuticals.